Form 4: Athira Pharma's Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Javier San Martin, Chief Medical Officer of Athira Pharma, reports acquisition and disposal of company stock related to RSU vesting and tax obligations.
Summary
- On December 31, 2024, Javier San Martin, the Chief Medical Officer of Athira Pharma, acquired 46,667 shares of common stock through the vesting of restricted stock units (RSUs).
- On January 2, 2025, San Martin disposed of 10,826 shares of common stock at a weighted-average price of $0.5619 per share.
- The sale was to cover tax withholding and remittance obligations related to the RSU vesting, as per the company's mandatory 'sell to cover' policy.
- Following these transactions, San Martin directly owns 35,841 shares of Athira Pharma's common stock.
- San Martin also holds 93,333 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine transactions related to executive compensation and tax obligations.
Future Outlook
The reporting person will continue to vest in the remaining RSUs on June 30, 2025, and December 31, 2025, subject to continued service with the company.
Industry Context
Form 4 filings are standard practice for company insiders and provide transparency into their transactions in the company's stock. This filing indicates routine transactions related to equity compensation.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| October 1, 2024 | Reporting person was granted 140,000 RSUs. |
| December 31, 2024 | Vesting of 1/3 of RSUs (46,667 shares). |
| December 31, 2024 | Acquisition of 46,667 shares of common stock through RSU vesting. |
| January 2, 2025 | Sale of 10,826 shares of common stock to cover tax obligations. |
| June 30, 2025 | Vesting of 1/3 of RSUs. |
| December 31, 2025 | Vesting of 1/3 of RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.